Voltas Q1 FY27 Results Analysis: PAT Surges 52%, UCP Margin Expands 167 bps
Cofacto Research
Updated August 14, 2026
2 min read
Positive
Voltas Ltd's Q1 FY27 numbers came in strong, with revenue of Rs. 4,673.50 Cr (+18.66% YoY) and PAT growth of +52.20% YoY. Here's a quick read of what worked, what to watch, and what management said.
Quick Details| Results date | August 14, 2026 |
|---|
| Quarter | Q1 FY 2026-2027 |
|---|
| Revenue (Q1) | Rs. 4,673.50 Cr (+18.66% YoY) |
|---|
| PAT (Q1) | Rs. 213.76 Cr (+52.20% YoY) |
|---|
| EBITDA margin | 4.88% (+100 bps YoY) |
|---|
| EPS (Q1) | Rs. 6.46 (+52.00% YoY) |
|---|
| Market cap | Rs. 43,869.45 Cr |
|---|
| CMP | Rs. 1,325.00 |
|---|
Quarter Snapshot
Voltas reported strong Q1FY27 results with 18.66% revenue growth and 52.20% PAT growth, driven by a stellar UCP segment (32% revenue growth, 167 bps margin expansion). The company gained RAC market share to 17.3% and maintained EMPS margins above the guided 5% floor despite a 27% revenue decline. JV losses widened, but the core business demonstrated strong execution.
Key Investment Insights
Key Positives
- Revenue grew 18.66% YoY to Rs.4,673.50 Cr, with UCP segment up 32.28% YoY
- EBITDA margin expanded 100 bps to 4.88%, with PAT growing 52.20% YoY to Rs.213.76 Cr
- UCP segment profit nearly doubled, with EBIT margin improving 167 bps to 5.31%
- RAC volumes grew 45% YoY, with 1 million ACs sold in 81 days
- Secondary RAC market share reached 17.3%, leading nearest competitor by 4 percentage points
- EMPS EBIT margin held above 5% guided floor at 5.62% despite 27% revenue decline
Risk Factors
- EMPS revenue declined 27.12% YoY due to unwind of large prior-year project base and Middle East geopolitical delays
- JV/associate losses widened to Rs.37.24 Cr from Rs.25.88 Cr YoY, primarily from Voltbek scaling
- UCP margin improvement partly benefited from inventory base effect (swing of Rs.289 Cr in inventory change line)
Disclaimer: This results analysis is published for educational and informational purposes only. It is not investment advice, not a recommendation to buy, sell or hold any security.
Powered by Cofacto — AI research platform for Indian stocks, every claim cited from primary filings
Login Now